Developing New Clinical Management Strategies for Antidepressant Treatments
Phase of Trial: Phase IV
Latest Information Update: 10 Jul 2017
Price : $35 *
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 08 Jun 2017 Status changed from active, no longer recruiting to completed.
- 06 Apr 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
- 06 Apr 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov record.